Trials / Completed
CompletedNCT02693522
Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
Phase III of the Comparative Study on the Efficacy and Safety of Recombinant Somatropin Administered to Patients With Adult Growth Hormone Deficiency
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of recombinant human growth hormone on adult growth hormone deficiency
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin | Subcutaneous injection |
| DRUG | Eutropin | Subcutaneous injection |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2004-12-01
- Completion
- 2004-12-01
- First posted
- 2016-02-26
- Last updated
- 2016-02-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02693522. Inclusion in this directory is not an endorsement.